Low toxic maghemite nanoparticles for theranostic applications

Elena A Kuchma,* Peter V Zolotukhin, Anna A Belanova, Mikhail A Soldatov, Tatiana A Lastovina, Stanislav P Kubrin, Anatoliy V Nikolsky, Lidia I Mirmikova, Alexander V Soldatov* The Smart Materials Research Center, Southern Federal University of Russia, Rostov-on-Don, Russia *These authors contribu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kuchma EA, Zolotukhin PV, Belanova AA, Soldatov MA, Lastovina TA, Kubrin SP, Nikolsky AV, Mirmikova LI, Soldatov AV
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/57906359fc5542bcaa69ab4641a21fe4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:57906359fc5542bcaa69ab4641a21fe4
record_format dspace
spelling oai:doaj.org-article:57906359fc5542bcaa69ab4641a21fe42021-12-02T01:32:09ZLow toxic maghemite nanoparticles for theranostic applications1178-2013https://doaj.org/article/57906359fc5542bcaa69ab4641a21fe42017-08-01T00:00:00Zhttps://www.dovepress.com/low-toxic-maghemite-nanoparticles-for-theranostic-applications-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Elena A Kuchma,* Peter V Zolotukhin, Anna A Belanova, Mikhail A Soldatov, Tatiana A Lastovina, Stanislav P Kubrin, Anatoliy V Nikolsky, Lidia I Mirmikova, Alexander V Soldatov* The Smart Materials Research Center, Southern Federal University of Russia, Rostov-on-Don, Russia *These authors contributed equally to this work Background: Iron oxide nanoparticles have numerous and versatile biological properties, ranging from direct and immediate biochemical effects to prolonged influences on tissues. Most applications have strict requirements with respect to the chemical and physical properties of such agents. Therefore, developing rational design methods of synthesis of iron oxide nanoparticles remains of vital importance in nanobiomedicine.Methods: Low toxic superparamagnetic iron oxide nanoparticles (SPIONs) for theranostic applications in oncology having spherical shape and maghemite structure were produced using the fast microwave synthesis technique and were fully characterized by several complementary methods (transmission electron microscopy [TEM], X-ray diffraction [XRD], dynamic light scattering [DLS], X-ray photoelectron spectroscopy [XPS], X-ray absorption near edge structure [XANES], Mossbauer spectroscopy, and HeLa cells toxicity testing).Results: TEM showed that the majority of the obtained nanoparticles were almost spherical and did not exceed 20 nm in diameter. The averaged DLS hydrodynamic size was found to be ~33 nm, while that of nanocrystallites estimated by XRD was ~16 nm. Both XRD and XPS studies evidenced the maghemite (γ-Fe2O3) atomic and electronic structure of the synthesized nanoparticles. The XANES data analysis demonstrated the structure of the nanoparticles being similar to that of macroscopic maghemite. The Mossbauer spectroscopy revealed the γ-Fe2O3 phase of the nanoparticles and vibration magnetometry study showed that reactive oxygen species in HeLa cells are generated both in the cytoplasm and the nucleus.Conclusion: Quasispherical Fe3+ SPIONs having the maghemite structure with the average size of 16 nm obtained by using the fast microwave synthesis technique are expected to be of great value for theranostic applications in oncology and multimodal anticancer therapy. Keywords: magnetic nanoparticles, SPIONs, maghemite, theranostics in oncology, toxicity, ROSKuchma EAZolotukhin PVBelanova AASoldatov MALastovina TAKubrin SPNikolsky AVMirmikova LISoldatov AVDove Medical Pressarticlemagnetic nanoparticlesSPIONsMaghemitetheranostics in oncologytoxicityROS.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 6365-6371 (2017)
institution DOAJ
collection DOAJ
language EN
topic magnetic nanoparticles
SPIONs
Maghemite
theranostics in oncology
toxicity
ROS.
Medicine (General)
R5-920
spellingShingle magnetic nanoparticles
SPIONs
Maghemite
theranostics in oncology
toxicity
ROS.
Medicine (General)
R5-920
Kuchma EA
Zolotukhin PV
Belanova AA
Soldatov MA
Lastovina TA
Kubrin SP
Nikolsky AV
Mirmikova LI
Soldatov AV
Low toxic maghemite nanoparticles for theranostic applications
description Elena A Kuchma,* Peter V Zolotukhin, Anna A Belanova, Mikhail A Soldatov, Tatiana A Lastovina, Stanislav P Kubrin, Anatoliy V Nikolsky, Lidia I Mirmikova, Alexander V Soldatov* The Smart Materials Research Center, Southern Federal University of Russia, Rostov-on-Don, Russia *These authors contributed equally to this work Background: Iron oxide nanoparticles have numerous and versatile biological properties, ranging from direct and immediate biochemical effects to prolonged influences on tissues. Most applications have strict requirements with respect to the chemical and physical properties of such agents. Therefore, developing rational design methods of synthesis of iron oxide nanoparticles remains of vital importance in nanobiomedicine.Methods: Low toxic superparamagnetic iron oxide nanoparticles (SPIONs) for theranostic applications in oncology having spherical shape and maghemite structure were produced using the fast microwave synthesis technique and were fully characterized by several complementary methods (transmission electron microscopy [TEM], X-ray diffraction [XRD], dynamic light scattering [DLS], X-ray photoelectron spectroscopy [XPS], X-ray absorption near edge structure [XANES], Mossbauer spectroscopy, and HeLa cells toxicity testing).Results: TEM showed that the majority of the obtained nanoparticles were almost spherical and did not exceed 20 nm in diameter. The averaged DLS hydrodynamic size was found to be ~33 nm, while that of nanocrystallites estimated by XRD was ~16 nm. Both XRD and XPS studies evidenced the maghemite (γ-Fe2O3) atomic and electronic structure of the synthesized nanoparticles. The XANES data analysis demonstrated the structure of the nanoparticles being similar to that of macroscopic maghemite. The Mossbauer spectroscopy revealed the γ-Fe2O3 phase of the nanoparticles and vibration magnetometry study showed that reactive oxygen species in HeLa cells are generated both in the cytoplasm and the nucleus.Conclusion: Quasispherical Fe3+ SPIONs having the maghemite structure with the average size of 16 nm obtained by using the fast microwave synthesis technique are expected to be of great value for theranostic applications in oncology and multimodal anticancer therapy. Keywords: magnetic nanoparticles, SPIONs, maghemite, theranostics in oncology, toxicity, ROS
format article
author Kuchma EA
Zolotukhin PV
Belanova AA
Soldatov MA
Lastovina TA
Kubrin SP
Nikolsky AV
Mirmikova LI
Soldatov AV
author_facet Kuchma EA
Zolotukhin PV
Belanova AA
Soldatov MA
Lastovina TA
Kubrin SP
Nikolsky AV
Mirmikova LI
Soldatov AV
author_sort Kuchma EA
title Low toxic maghemite nanoparticles for theranostic applications
title_short Low toxic maghemite nanoparticles for theranostic applications
title_full Low toxic maghemite nanoparticles for theranostic applications
title_fullStr Low toxic maghemite nanoparticles for theranostic applications
title_full_unstemmed Low toxic maghemite nanoparticles for theranostic applications
title_sort low toxic maghemite nanoparticles for theranostic applications
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/57906359fc5542bcaa69ab4641a21fe4
work_keys_str_mv AT kuchmaea lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT zolotukhinpv lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT belanovaaa lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT soldatovma lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT lastovinata lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT kubrinsp lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT nikolskyav lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT mirmikovali lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT soldatovav lowtoxicmaghemitenanoparticlesfortheranosticapplications
_version_ 1718403014527549440